IL4 and Alzheimer disease: ,89 Biologics (interleukin-4 and -13 inhibitors) and small molecule inhibitors (oral Janus kinase inhibitors) that specifically target cytokines and pathways implicated in AD pathogenesis94 are now available for pediatric patients with AD.